MiMedx Group, Inc. Operating Lease, Weighted Average Discount Rate, Percent
MiMedx Group, Inc. (MDXG) had Operating Lease, Weighted Average Discount Rate, Percent of 6.90% as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-02-25
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.90%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.90%.
- 2023-12-31: Operating Lease, Weighted Average Discount Rate, Percent 8.30%.
- 2022-12-31: Operating Lease, Weighted Average Discount Rate, Percent 8.30%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-12-31 | 6.90% 10-K · filed 2026-02-25 |
| 2024-12-31 | 6.90% 10-K · filed 2026-02-25 |
| 2023-12-31 | 8.30% 10-K · filed 2025-02-26 |
| 2022-12-31 | 8.30% 10-K · filed 2024-02-28 |
| 2021-12-31 | 8.40% 10-K · filed 2023-02-28 |
| 2021-03-31 | 10.00% 10-Q · filed 2021-04-28 |
| 2020-12-31 | 10.00% 10-K · filed 2022-02-28 |
| 2020-09-30 | 10.00% 10-Q · filed 2020-11-04 |
| 2020-06-30 | 11.50% 10-Q · filed 2020-08-04 |
| 2020-03-31 | 11.50% 10-Q · filed 2020-07-06 |
| 2019-12-31 | 11.50% 10-K · filed 2021-03-08 |
| 2019-09-30 | 11.50% 10-Q · filed 2020-07-06 |
| 2019-06-30 | 11.50% 10-Q · filed 2020-07-06 |
| 2019-03-31 | 11.50% 10-Q · filed 2020-07-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |